Headquartered in Scranton, PA, Noble Biomaterials develops, manufactures and markets advanced antimicrobial technologies designed to provide bacterial management, wound management and odor elimination solutions. Through the X-STATIC system, Noble delivers premier odor elimination solutions to leading sports apparel companies and world class bacterial management systems to global healthcare brands. The Company has more than 200 global licensees for products in the medical, defense, industrial and consumer markets and has offices in Europe, Asia and South America.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/10/12 | $8,000,000 | Series B |
DuPont Capital Management Northwater Capital Management | undisclosed |
